Board MeetingOutcome of Board Meeting
Neuland Labs' board approved consolidated FY26 results with Revenue at ₹2023 Cr & PAT at ₹364 Cr.
Neuland Laboratories LimitedNEULANDLAB · Filed with the exchange
They declared a final dividend of ₹34/share and plan a ₹143.4 Cr capacity expansion at Unit 1. Dr. Mauricio Futran was appointed as a new director.
No comments yet. Be the first.